Accord Challenges Novartis Blood Pressure Patent At Trial

By Ronan Barnard ( June 15, 2026, 5:20 PM BST) -- Accord told a London court Monday that protections for Novartis' blood pressure medication should be revoked, arguing that the patent does not pass the required legal tests....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login